SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : genelabs(gnlb)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Hua who wrote (186)2/15/2000 11:29:00 PM
From: Chuca Marsh   of 233
 
Agreed ( with you and other Threaders ) ( and Victims- BTW I got PMs and EMs from Net Buds who have Lupus ) and this part MUST BE STATED AGAIN, for their sakes:
""" ...Results Of Trial

In the double-blind placebo trial conducted by investigators at 27 sites
nationwide over a year, women treated with GL701 showed a 35%
greater response rate than the placebo group; and 66% of patients
responded to treatment with the drug, compared with 49% who
responded to the placebo, the company said.

..."""
ChuckaDoulbeblind means SOMETHINGMORETHAN...anything HE CAN UNDERSTAND. The Blind leading the Blind comes to mind with THAT DAM ANAYLIST! BLINDSIDEDBYADAMBLIND...methinks he was in a duck blind. Blinders on a horses ass..alsocometomymindseye(blind). Hey, Ms Bannister- keep up the good work with all the gruff - that just might not be for NOT for 2/3rds-ie 66% !!! ! Contrats GNLB LONGS. Yes, I held.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News